摘要
目的:分析行肝癌根治术的老年肝癌患者的临床特点及安全性。方法:选2019.01~2020.01重庆市合川区中医院外一科收治的85例行肝癌根治术的老年肝癌患者进行研究,根据年龄分为2组,对照组(n = 68,非老年组),试验组(n = 17,老年组),对比一般资料、术后疗效等相关指标。结果:实验组与对照组性别、病程、甲胎蛋白 】400 μg/L发生率、术中出血量、术后并发症发生率对比无显著差异,P 】0.05。试验组乙型肝炎表面抗原、乙型肝炎病毒及丙型肝炎病毒感染率、肝硬化发生率显著低于对照组,P 【0.05。结论:行肝癌根治术的老年肝癌患者安全性与非老年患者一致,但肝癌根治术可提高老年肝癌患者预期寿命。
Objective: To analyze the clinical characteristics and safety of elderly patients with liver cancer undergoing radical resection of liver cancer. Methods: From January 2019 to January 2020, 85 elderly patients with liver cancer who underwent radical resection of liver cancer and were admitted to the First Department of Chongqing Hechuan Traditional Chinese Medicine Hospital were selected for the study. They were divided into 2 groups according to their age, the control group (n = 68, non-elderly group), and the trial group (n = 17, elderly group), to compare general data, postoperative efficacy and other related indicators. Results: There were no significant differences between the experimental group and the control group in terms of gender, course of disease, incidence of alpha-fetoprotein >400 μg/L, intraoperative blood loss, and incidence of postoperative complications, P >0.05. The infection rate of hepatitis B surface antigen, hepatitis B virus and hepatitis C virus, and the incidence of liver cirrhosis in the experimental group were significantly lower than those in the control group, P <0.05. Conclusion: The safety of elderly liver cancer patients undergoing radical liver cancer surgery is the same as that of non-elderly patients, but radical liver cancer surgery can increase the life expectancy of elderly liver cancer patients.
出处
《临床医学进展》
2021年第8期3469-3473,共5页
Advances in Clinical Medicine
